Intellia Therapeutics (NTLA) Non-Current Deffered Revenue (2015 - 2025)
Intellia Therapeutics' Non-Current Deffered Revenue was $12.54 million in Q3 2025, down 44.5% from $22.61 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Non-Current Deffered Revenue (2015 - 2025) Analysis & Trends
At the end of FY2024, Non-Current Deffered Revenue at Intellia Therapeutics came in at $18.26 million, down 53.0% from FY2023.
- Non-Current Deffered Revenue shows a five-year compound annual growth rate of 2.5% (FY2019 to FY2024).
- In earlier years, Non-Current Deffered Revenue was $38.85 million in FY2023 (+94.9%), $19.93 million in FY2022 (-68.6%), $63.48 million in FY2021 (+23.5%) and $51.39 million in FY2020 (+218.5%).
- Quarterly Non-Current Deffered Revenue has moved between $12.54 million (Q2 2025) and $63.48 million (Q4 2021) over five years.
- Compared with a year earlier, Non-Current Deffered Revenue has declined for four straight quarters, with growth averaging 27.2% over the last eight quarters.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q1 2021 (growth of 252.0%); the worst was Q1 2023 (a decline of 72.0%).
- Per Business Quant data, NTLA's Non-Current Deffered Revenue in the three quarters before Q3 2025 was $12.54 million (Q2 2025), $13.16 million (Q1 2025) and $18.26 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Intellia Therapeutics | 1.69 Bn | 1.69 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 12.54 Mn |
| Jun 30, 2025 | 12.54 Mn |
| Mar 31, 2025 | 13.16 Mn |
| Dec 31, 2024 | 18.26 Mn |
| Sep 30, 2024 | 22.61 Mn |
| Jun 30, 2024 | 28.05 Mn |
| Mar 31, 2024 | 33.44 Mn |
| Dec 31, 2023 | 38.85 Mn |
| Sep 30, 2023 | 12.72 Mn |
| Jun 30, 2023 | 12.92 Mn |
| Mar 31, 2023 | 13.86 Mn |
| Dec 31, 2022 | 19.93 Mn |
| Sep 30, 2022 | 25.68 Mn |
| Jun 30, 2022 | 35.33 Mn |
| Mar 31, 2022 | 49.48 Mn |
| Dec 31, 2021 | 63.48 Mn |
| Sep 30, 2021 | 63.02 Mn |
| Jun 30, 2021 | 40.21 Mn |
| Mar 31, 2021 | 45.83 Mn |
| Dec 31, 2020 | 51.39 Mn |
API Access
Intellia Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();